Haematology Flashcards
(180 cards)
What is Antiphospholipid syndrome?
Characterized by the presence of antiphospholipid antibodies (APL) in the plasma, venous and arterial thromboses, recurrent foetal loss and thrombocytopenia
What is the aetiology of Antiphospholipid syndrome?
APL are directed against plasma proteins bound to anionic phospholipids (e.g. b2 glycoprotein-I)
APL may develop in susceptible individuals (e.g. those with rheumatic diseases such as SLE) following exposure to infectious agents
Once APL are present, a ‘second-hit’ is needed for the development of the syndrome
Complement activation is critical for pregnancy complications
What is the epidemiology of Antiphospholipid syndrome?
Can occur in patients without an underlying systemic autoimmune disease (primary APS) or with other autoimmune disease (also known as secondary APS), particularly systemic lupus erythematosus (SLE)
More common in young women
Accounts for 20% of strokes in <45-year- olds and 27% of women with >2 miscarriages
What are the presenting symptoms of Antiphospholipid syndrome?
Recurrent miscarriages History of arterial thromboses (stroke), venous throm- boses (DVT, pulmonary embolism) Headaches (migraine) Chorea (involuntary movement) Epilepsy
What are the signs of Antiphospholipid syndrome on physical examination?
Features of thrombocytopenia: petechial rash or symptoms of mucosal bleeding
Arthralgia/arthritis
Livedo reticularis: mottled purplish discoloration of the skin, which can be blanching or non-blanching on pressure
Signs of SLE (malar flush, discoid lesions, photosensitivity)
Valvular disease (cardiac murmur): UNCOMMON
What are the appropriate investigations for Antiphospholipid syndrome?
Lupus anticoagulant assays: positive on 2 occasions, 12 weeks apart, clotting assays showing effects of APL on the phospholipid-dependent factors in the coagulation cascade
ELISA testing for Anticardiolipin antibody (of IgG or IgM) and anti-b2-GPI antibodies
ANA, ds DNA, extractable nuclear antigen antibodies: elevated in SLE
Bloods:
-FBC (low platelets), ESR (usually normal), U&Es (APL nephropathy), clotting screen (prolonged APTT)
What is Aplastic anaemia?
Characterized by diminished haematopoietic precursors in the bone marrow and deficiency of all blood cell elements (pancytopaenia)- no abnormal cells
What is the aetiology of Aplastic anaemia?
Most often Idiopathic (>40%):
-May be due to destruction or suppression of stem cells by autoimmune mechanisms
Acquired:
-Drugs (chloramphenicol, NSAIDs, gold, alkylating agents, antiepileptics, sulphonamides, methotrexate), chemicals (DDT, benzene), radiation, viral infection (B19 parvovirus, HIV, EBV), paroxysmal nocturnal haemoglobinuria
Inherited:
-Fanconi’s anaemia, dyskeratosis congenita (associated with reticulated hyperpigmented rash, nail dystrophy and mucosa leukoplakia)
What is the epidemiology of Aplastic anaemia?
Annual incidence: 2–4 in per million
Can occur at any age
Slightly more common in males
What are the presenting symptoms of Aplastic anaemia?
Slow (months) or rapid (days) onset Anaemia: -Tiredness -Lethargy -Dyspnoea Thrombocytopaenia: -Easy bruising -Bleeding gums -Epistaxis Leukopenia: Increased frequency and severity of infections
What are the signs of Aplastic anaemia on physical examination?
Anaemia: Pale Thrombocytopaenia: Petechiae, bruises Leukopaenia: -Multiple bacterial or fungal infections No hepatomegaly, splenomegaly or lymphadenopathy
What are the appropriate investigations for Aplastic anaemia?
1st line:
-FBC: 2 or more cytopenias among the following:
*Hb <100 g/L (<10 g/dL)
*Platelet <50 × 10⁹/L
*Absolute neutrophil count <1.5 × 10⁹/L
Reticulocyte count: low or absent reticulocytes
Bone marrow biopsy (and cytogenetic analyses):
-Hypocellular marrow with no abnormal cell population
-Marrow space is composed mostly of fat cells and marrow stroma
-Exclusion of other causes e.g. lymphoma, leukaemia, malignancies, myeloma
Others:
Blood film: To exclude leukaemia (absence of abnormal circulating white blood cells)
What is the criteriea for severe aplastic anaemia?
Marrow showing <25 % of normal cellularity
OR
Marrow showing <50 % of normal cellularity, <30% of the cells are haematopoietic plus 2 of the following:
-neutrophils < 0.5x10⁹/L
-platelets < 20x10⁹/L
-reticulocytes < 40x10⁹/L
What is Blood product transfusion?
A lifesaving procedure to treat hemorrhages and to improve oxygen delivery to tissues
What are the indications for Blood product transfusion (red cell)?
Symptomatic anemia (causing shortness of breath, dizziness, congestive heart failure, and decreased exercise tolerance)
Acute sickle cell crisis
Acute blood loss of more than 30 percent of blood volume
What are the indications for Blood product transfusion (fresh frozen plasma)?
Can be used for reversal of anticoagulant effects
What are the indications for Blood product transfusion (Platelet transfusion)?
To prevent haemorrhage in patients with thrombocytopenia or platelet function defects
What are the indications for Blood product transfusion (Cryoprecipitate)?
Used in cases of hypofibrinogenemia, which most often occurs in the setting of massive hemorrhage or consumptive coagulopathy
What are the possible complications of Blood product transfusion?
Acute complications occur within minutes to 24 hours of the transfusion, whereas delayed complications may develop days, months, or even years later
*Infections are less common because of advances in the blood screening process
Non-infectious complications (acute): -Acute haemolytic reaction -Allergic/Anaphylactic reaction -Coagulation problems in massive transfusion -Metabolic derangements -Septic or bacterial contamination -Transfusion-associated circulatory overload Non-infectious complications (delayed): -Delayed haemolytic reaction -Iron overload -Post-transfusion purpura
Infectious complications:
- Hepatitis B virus
- Hepatitis C virus
- Human T-lymphotropic virus 1 or 2
- Human immunodeficiency virus
What is Disseminated intravascular coagulation (DIC)?
An acquired syndrome characterised by activation of coagulation pathways, resulting in formation of intravascular thrombi and depletion of platelets and coagulation factors
Thrombi may lead to vascular obstruction/ischaemia and multi-organ failure
What is the aetiology of Disseminated intravascular coagulation (DIC)?
Disease states that trigger systemic activation of coagulation may lead to DIC. Causes include:
- Sepsis/severe infection, major trauma or burns
- Some malignancies (acute myelocytic leukemia or metastatic mucin-secreting adenocarcinoma)
- Obstetric disorders (amniotic fluid embolism, eclampsia, abruptio placentae, retained dead fetus syndrome)
- Severe organ destruction or failure (severe pancreatitis, acute hepatic failure)
- Vascular disorders (Kasabach-Merritt syndrome or giant haemangiomas, large aortic aneurysms)
- Severe toxic or immunological reactions (blood transfusion reaction or haemolytic reactions, organ transplant rejection, snake bite)
What is the epidemiology of Disseminated intravascular coagulation (DIC)?
Many conditions can cause DIC, therefore, the overall incidence is difficult to determine
Seen in any severely ill patient
What are the presenting symptoms of Disseminated intravascular coagulation (DIC)?
The patient is severely unwell with symptoms of:
- The underlying disease
- Confusion
- Dyspnoea
- Evidence of bleeding
What are the signs of Disseminated intravascular coagulation (DIC) on physical examination?
Signs of the underlying aetiology, fever, evidence of shock (hypotension, tachycardia, oliguria)
Acute DIC:
-Petechiae
-Purpura
-Ecchymoses
-Epistaxis
-Mucosal bleeding
-Overt haemorrhage
-Signs of end organ damage (e.g. local infarction or gangrene), respiratory distress, oliguria caused by renal failure
Chronic DIC:
-Signs of deep venous or arterial thrombosis or embolism
-Superficial venous thrombosis, especially without varicose veins